# Gates Foundation

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/gates-foundation
Canonical HTML page: https://gethealthbrief.com/entity/gates-foundation

## Timeline

- **2026-09-09**: Americares announces record anonymous gift — Americares announced a $50 million gift from an unnamed Connecticut family, the largest donation in its history, to expand medicine delivery to high-need areas.
- **2026-03-24**: Paysign 2026 Outlook — Paysign projects 30-35% revenue growth for the coming fiscal year.
- **2026-03**: Bezos parents commit $500 million to UNICEF — Jeff Bezos' parents pledged up to $500 million for UNICEF's Child Nutrition Fund, one of several large private responses to global aid funding gaps.
- **2026-01-15**: Recombinant Albumin Launch — Dyadic and ProLiant initiate commercial launch of recombinant albumin.
- **2025-12-31**: Dyadic Year-End Cash — Dyadic ends fiscal year with $8.6 million in cash and liquid assets.
- **2025-11-01**: Precigen Commercial Launch — Initial commercial shipments of Papzimius for adult RRP begin.

## Recent coverage (2 stories)

### Record $50M Gift Keeps Medicines Flowing to Global Health Clinics
2026-09-09 17:56:23 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

A $50 million anonymous gift to Americares will expand medicine delivery to high-need health centers as USAID cuts destabilize maternal, child, and HIV programs. The record donation shows how health philanthropies are stepping into funding gaps, though experts warn private wealth cannot replace billions lost.
Full story: https://gethealthbrief.com/story/record-50m-gift-americares-global-health-clinics

### Biotech Commercialization Pivot: Dyadic and Precigen Scale Post-R&D
2026-03-26 00:19:20 · Sentiment: Positive · Impact: 6/10 · Sources: 5

The Q4 2025 earnings cycle marks a critical transition for mid-cap biotech and health-IT firms as they shift from R&D-heavy profiles to commercial-stage entities. Key players like Dyadic and Precigen are reporting initial product revenues and expanded distribution networks, while service providers like Paysign see massive growth in patient affordability programs.
Full story: https://gethealthbrief.com/story/biotech-commercialization-pivot-dyadic-precigen-2025

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.